1. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
2. |
Individual tailoring of heart failure therapy: achieving the best fit |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
3. |
Azithromycin preferable for CAP |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
4. |
'Prevnar' for pneumococcal disease - it makes cents |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 5-6
Amanda Cameron,
Preview
|
|
摘要:
Hot on the heels of the release of a study demonstrating the cost-saving potential of Wyeth-Lederle's heptavalent pneumococcal conjugate vaccine 'Prevnar',1researchers at the 5th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) [Arlington, US; May 2000] announced more good news for the vaccine product. According to the results of their modelling study, routine vaccination of infants and children aged < 5 years againstStreptococcus pneumoniaewould substantially reduce the costs of medical treatment and lost productivity related to pneumococcal disease.2These findings have importance for healthcare payers and societies worldwide, sinceS. pneumoniaeis a leading cause of meningitis, bacteraemia, pneumonia, otitis media and sinusitis - diseases which represent a significant economic burden.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
5. |
Antidepressants, anxiolytics, hypnotics - a common cocktail |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
6. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
7. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
8. |
Meningococcal group C conjugate vaccine immunogenic in infants |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
9. |
Short-course therapy effective in early breast cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 11-11
Carmen Innes,
Preview
|
|
摘要:
Three months of chemotherapy with doxorubicin plus cyclophosphamide appears to offer the same benefits as 6 months' treatment with cyclophosphamide, methotrexate plus fluorouracil (CMF) in women with estrogen receptor (ER)-negative breast cancer that has not spread to the lymph nodes (node-negative), with no additional toxicity. This means that doxorubicin plus cyclophosphamide may be easily substituted for CMF, thus saving women from extra months of therapy. The data, presented at the 36th Annual Meeting of the American Society of Clinical Oncology [New Orleans, US; May 2000], are from a National Surgical Adjuvant Breast and Bowel Project (NSABP) study and represent the largest head-to-head trial of the 2 commonly used therapies. The study also found that the addition of tamoxifen in such patients offers no extra benefits.
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|
10. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1242,
2000,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2000
数据来源: ADIS
|